Paper33717596
Coagulation disorders and thromboembolic disease in COVID-19: review of current evidence in search of a better approach.
García-Ortega A and 5 others. J Thorac Dis, 2021. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Coagulation disorders and thromboembolic disease in COVID-19: review of current evidence in search of a better approach. Papers, record 33717596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33717596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Coagulation disorders and thromboembolic disease in COVID-19: review of current evidence in search of a better approach.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11740687 | Regulatory role of cytokines in disseminated intravascular coagulation. | Semin Thromb Hemost | 2001 | https://conductscience.org/library/papers/11740687 | PubMed |
| 2 | 32907890 | Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. | Eur Respir J | 2020 | https://conductscience.org/library/papers/32907890 | PubMed |
| 3 | 32302453 | Thromboinflammation and the hypercoagulability of COVID-19. | J Thromb Haemost | 2020 | https://conductscience.org/library/papers/32302453 | PubMed |
| 4 | 15507261 | The impact of the inflammatory response on coagulation. | Thromb Res | 2004 | https://conductscience.org/library/papers/15507261 | PubMed |
| 5 | 984062 | Intravascular coagulation associated with the adult respiratory distress syndrome. | Am J Med | 1976 | https://conductscience.org/library/papers/984062 | PubMed |
| 6 | 32841275 | Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study. | PLoS One | 2020 | https://conductscience.org/library/papers/32841275 | PubMed |
| 7 | 30123926 | Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant). | Curr Rheumatol Rep | 2018 | https://conductscience.org/library/papers/30123926 | PubMed |
| 8 | 32169400 | Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. | Prog Cardiovasc Dis | 2020 | https://conductscience.org/library/papers/32169400 | PubMed |
| 9 | 14610013 | Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. | Circulation | 2003 | https://conductscience.org/library/papers/14610013 | PubMed |
| 10 | 27969572 | Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis. | J Crit Care | 2017 | https://conductscience.org/library/papers/27969572 | PubMed |
| 11 | 32405101 | Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. | Thromb Res | 2020 | https://conductscience.org/library/papers/32405101 | PubMed |
| 12 | 32694078 | Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology. | Rev Esp Cardiol (Engl Ed) | 2020 | https://conductscience.org/library/papers/32694078 | PubMed |
| 13 | 15900257 | Thrombosis risk assessment as a guide to quality patient care. | Dis Mon | 2005 | https://conductscience.org/library/papers/15900257 | PubMed |
| 14 | 26867832 | Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. | Chest | 2016 | https://conductscience.org/library/papers/26867832 | PubMed |
| 15 | 24508449 | Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: a systematic review and meta-analysis. | Thromb Res | 2014 | https://conductscience.org/library/papers/24508449 | PubMed |
| 16 | 31978945 | A Novel Coronavirus from Patients with Pneumonia in China, 2019. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31978945 | PubMed |
| 17 | 17646601 | Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. | Arch Intern Med | 2007 | https://conductscience.org/library/papers/17646601 | PubMed |
| 18 | 32031570 | Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. | JAMA | 2020 | https://conductscience.org/library/papers/32031570 | PubMed |
| 19 | 32239799 | The versatile heparin in COVID-19. | J Thromb Haemost | 2020 | https://conductscience.org/library/papers/32239799 | PubMed |
| 20 | 32246450 | D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. | Thromb Haemost | 2020 | https://conductscience.org/library/papers/32246450 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42356487 | Selected Cannabinoids, Cannabimimetic Agents and Artemisia Combinations as Theoretical Adjunct Strategies Against COVID-19. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356487 | PubMed |
| 41612230 | Effects of antiphospholipid antibodies in the severity and outcome of COVID-19. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/41612230 | PubMed |
| 40732143 | Pulmonary Embolism in COVID-19: Trends from a Single-Center Study Across Ten Pandemic Waves in Romania. | Microorganisms | 2025 | https://conductscience.org/library/papers/40732143 | PubMed |
| 38991681 | Background incidence rates of health outcomes of interest for COVID-19 vaccine safety monitoring in a US population: a claims database analysis. | BMJ Open | 2024 | https://conductscience.org/library/papers/38991681 | PubMed |
| 36551272 | Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients. | Biomolecules | 2022 | https://conductscience.org/library/papers/36551272 | PubMed |
| 36444620 | The potential link between Covid-19 and multiple myeloma: A new saga. | Immun Inflamm Dis | 2022 | https://conductscience.org/library/papers/36444620 | PubMed |
| 36119336 | SARS-CoV-2 triggered seizure complicated by fatal subdural hematoma under edoxaban and clopidogrel. | J Family Med Prim Care | 2022 | https://conductscience.org/library/papers/36119336 | PubMed |
| 35337387 | Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35337387 | PubMed |
| 35162207 | Cardiovascular System during SARS-CoV-2 Infection. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35162207 | PubMed |
| 35056076 | Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/35056076 | PubMed |
| 34900633 | Malnutrition and Venous Thromboembolism are Specific Issues in Elderly Patients with Coronavirus Disease 2019. | J Transl Int Med | 2021 | https://conductscience.org/library/papers/34900633 | PubMed |
| 34868570 | Massive pulmonary embolism complicating mild Covid 19 pneumonia: Successful systemic thrombolysis using rt-PA in an elderly patient: A case report. | Ann Med Surg (Lond) | 2022 | https://conductscience.org/library/papers/34868570 | PubMed |
| 34845920 | Sex-, Race- and Ethnicity-Based Differences in Thromboembolic Events Among Adults Hospitalized With COVID-19. | J Am Heart Assoc | 2021 | https://conductscience.org/library/papers/34845920 | PubMed |
| 34414665 | Follow-up of renal transplant recipients after acute COVID-19-A prospective cohort single-center study. | Immun Inflamm Dis | 2021 | https://conductscience.org/library/papers/34414665 | PubMed |
| 34347185 | Colon perforation as a complication of COVID-19: a case report. | Surg Case Rep | 2021 | https://conductscience.org/library/papers/34347185 | PubMed |
| 34332403 | Thromboprophylaxis in COVID-19 - Rationale and considerations. | Adv Biol Regul | 2021 | https://conductscience.org/library/papers/34332403 | PubMed |
| 34200990 | The Right Ventricle in COVID-19. | J Clin Med | 2021 | https://conductscience.org/library/papers/34200990 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33717596
GET https://conductscience.org/api/papers/v1/33717596/references?page=2